Business
IM Cannabis to Report First Quarter 2022 Financial Results on Thursday, May 12 at 5:00 p.m. ET
TORONTO, Canada and GLIL YAM, Israel, May 5, 2022 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading
About this update from Im Cannabis Corp.
[{"type":"text","content":"TORONTO, Canada and GLIL YAM, Israel, May 5, 2022 /PRNewswire/ -- IM Cannabis Corp. (the \"Company\" or \"IM Cannabis\") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, will report operational and financial results for the first quarter ended March 31, 2022 after market close on Thursday, May 12, 2022.\n \n \nManagement will host a conference call to discuss the results, followed by a question-and-answer session from participants. To participate, please use the following information:\nQ1 2022 Conference Call \nDate: Thursday, May 12, 2022\nTime: 5:00 p.m. Eastern time\nU.S./Canada Dial-in: 1-844-825-9789\nIsrael Dial-in: 1-80-9213284\nGermany Dial-in: 0-800-5895393\nInternational Dial-in: 1-412-317-5180\nConference ID: 10167199\nWebcast: IMCC Q1 2022 Webcast\nPlease dial in at least 10 minutes before the start of the call to ensure timely participation.\nA playback of the call will be available through Thursday, June 9, 2022. To listen, call 1-844-512-2921 within the United States or Canada or 1-412-317-6671 when calling internationally and enter replay pin number 10167199. A recording of the conference call will also be available on the events & presentations section of the IM Cannabis investor relations website linked here.\nAbout IM Cannabis Corp.\nIM Cannabis (NASDAQ: IMCC, CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers. IM Cannabis is one of the very few companies with operations in Israel, Germany and Canada, the three largest federally legal markets. The ecosystem created through its international operations leverages the Company's unique data-driven perspective and product supply chain globally. With its commitment to responsible growth and financial prudence, and the ability to operate within the strictest regulatory environments, the Company has quickly become one of the leading cultivators and distributors of high-quality cannabis globally.\nThe Company operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs through IMC Holdings Ltd. in Israel that enable the safe delivery and quality control of IM Cannabis products throughout the entire value chain. In Germany, the IM Cannabis ecosystem oper...